You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
Exclusive Interview with PharmaCann CEO Brett Novey PharmaCann CEO Brett Novey last spoke to New Cannabis Ventures in August 2021. During that conversation, he outlined the private cannabis company’s...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
PharmaCann Completes $40 Million Additional Issuance of Senior Secured Notes CHICAGO, January 20, 2022–(BUSINESS WIRE)–PharmaCann Inc. (“PharmaCann” or the “Company”), one of the largest, private, vertically integrated cannabis companies...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
PharmaCann and LivWell Enlightened Health Announce Planned Merger PharmaCann and LivWell’s transformative partnership will create a combined portfolio of approximately 60 dispensary licenses and 11 cultivation and production facilities...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
Exclusive Interview with PharmaCann CEO Brett Novey Private multi-state operator PharmaCann relies on a formula supported by its people, its foundational assets and financial discipline. CEO Brett Novey last...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
PharmaCann Completes $85 Million Senior Secured Note Offering CHICAGO, June 25, 2021 /PRNewswire/ — PharmaCann Inc., one of the largest vertically integrated cannabis companies in the United States, today...
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
Exclusive Interview with Ethos Cannabis CEO Teddy Scott, Ph.D., J.D. Ethos Cannabis was a relatively unknown player prior to the announcement that it would be acquiring assets from 4Front...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
Exclusive Interview with PharmaCann CEO Brett Novey Privately held MSO PharmaCann is building a cohesive footprint stretching from Illinois to the East Coast. CEO Brett Novey spoke with New...
Although just two years old, Pennsylvania’s medical cannabis market is booming. The program serves around 160,000 patients, and according to numerous statewide media accounts, there are persistent product shortages,...
Although Ohio legalized medical use of cannabis four years ago, the state has been slow to grow its program. Myriad regulations, along with delays in awarding licenses, kept the...
New York’s medical cannabis program has developed substantially over the past several years and is now dominated by publicly traded companies. While it appeared that 2019 would be the...
Innovative Industrial Properties Reports Third Quarter 2019 Results Acquisitions Drive 201% Q3 Rental Revenue, 314% Q3 Net Income and 270% Q3 AFFO Growth Year-over-Year SAN DIEGO, November 06, 2019–(BUSINESS...
MedMen Announces Termination of Merger Agreement With PharmaCann and Management Changes MedMen and PharmaCann terminate business combination agreement In conjunction with the termination, MedMen will be compensated with retail...
MedMen Announces Expiration of HSR Waiting Period for Proposed Acquisition of PharmaCann Expiration of HSR waiting period moves the transaction one step closer to completion Combined company would be...
MedMen Announces Preliminary Fourth Quarter 2019 Systemwide Revenue Results and Provides Additional Corporate Updates Pro forma fourth quarter systemwide revenue, including pending acquisitions, of US$61 million, representing an annualized...
Innovative Industrial Properties Expands Partnership with PharmaCann with Acquisition and Long-Term Lease of Pennsylvania Property SAN DIEGO, August 12, 2019–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only...
This is a copy of the December 30th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, As we reach the end of 2018,...
MedMen Signs Definitive Agreement for the Acquisition of PharmaCann MedMen will undertake a re-organization whereby a new holding company will acquire each of MedMen and PharmaCann. The acquisition doubles...